相关实验视频

Updated: Mar 15, 2026

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

用于治疗带转移的不可切除结肠直肠腺癌的区域疗法

Shray Malik¹, Vanessa Le¹, Farshid Dayyani²

¹Department of Surgery, University of California-Irvine, Orange, CA 92868, USA.

|March 14, 2026

概括

结肠直肠腹膜转移的预后很差. 本综述涵盖了目前用于不可切除疾病的区域疗法和未来的方向,解决了这些患者治疗选择中的关键差距.

科学领域:

在瘤学瘤学.
手术瘤学手术瘤学
胃肠病学胃肠病学

背景情况:

结直肠外皮转移与预后不佳有关.
细胞还原性手术改善了可切除腹癌的结果.
对于无法切除的腹膜疾病,存在有限的治疗选择.

研究的目的:

审查目前关于不可切割结直肠外皮转移的区域疗法的数据.
发现当前治疗策略中的差距.
假设区域治疗的未来方向.

主要方法:

关于区域疗法的现有研究的文献综述.
对早期临床试验数据的分析.
讨论当前的治疗景观和未来的研究.

主要成果:

细胞还原性手术对可切除疾病的患者有好处.
在不可切除的病例中,非手术区域疗法尚未得到研究.
在管理不可切除的结肠直肠腹转移方面存在重大差距.

结论:

对于不可切除的结直肠外皮转移,急需有效的区域疗法.
对非手术区域治疗的进一步研究是有必要的.
未来的战略可能涉及新的区域方法来改善结果.

关键词:

结肠直肠周围瘤转移.地方区域治疗疗法没有切除的腹癌.

更多相关视频

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...